CONSEQUENCES OF UNCONTROLLED CALCIUM ENTRY AND ITS PREVENTION WITH CALCIUM-ANTAGONISTS

被引:54
作者
FLECKENSTEIN, A
FREY, M
FLECKENSTEINGRUN, G
机构
关键词
D O I
10.1093/eurheartj/4.suppl_H.43
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:43 / 50
页数:8
相关论文
共 24 条
[1]  
[Anonymous], CALCIUM ANTAGONISM H
[2]  
BAJUSZ E, 1963, CONDITIONING FACTORS
[3]  
BING RJ, 1979, NEW DRUG THERAPY CAL, P27
[4]  
FLECKENS.A, 1969, PFLUG ARCH EUR J PHY, V307, pR25
[5]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[6]  
Fleckenstein A, 1974, Recent Adv Stud Cardiac Struct Metab, V4, P563
[7]  
Fleckenstein A, 1971, Verh Dtsch Ges Kreislaufforsch, V37, P345
[8]  
Fleckenstein A, 1975, Recent Adv Stud Cardiac Struct Metab, V6, P21
[9]  
Fleckenstein A, 1973, Recent Adv Stud Cardiac Struct Metab, V2, P455
[10]  
FLECKENSTEIN A, 1969, INT S DRUGS METABOLI, P11